Treatment of premenopausal endometrial hyperplasia by a combination of a long-acting estrogen and a cyclic progestogen.
D000328:Adult; D001706:Biopsy; D003475:Curettage; D003517:Cyclopentanes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D004714:Endometrial Hyperplasia / Q000188:drug therapy* / Q000473:pathology; D004717:Endometrium / Q000473:pathology; D004967:Estrogens / Q000008:administration & dosage*; D004987:Ethers / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006628:Hirsutism / Q000209:etiology; D006801:Humans; D008593:Menopause / Q000187:drug effects*; D008875:Middle Aged; D010507:Periodicity; D011374:Progesterone / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D011800:Quinestrol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014592:Uterine Hemorrhage / Q000209:etiology
D003517:Cyclopentanes; D003692:Delayed-Action Preparations; D004967:Estrogens; D004987:Ethers; D011374:Progesterone; D011800:Quinestrol